FDA Adverse Event Other Summary report: N

PIC INSUPEN

MDR report key: 3192597 · Received May 21, 2012

Report

Report Number
9612764-2013-00001
Event Type
Other
Date Received
May 21, 2012
Date of Event
April 29, 2013
Report Date
May 20, 2013
Manufacturer
ARTSANA S.P.A.
Product Code
FMI
PMA / PMN Number
K051783
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE PEN NEEDLE HAS BROKEN INSIDE THE ABDOMEN OF THE PT ((B)(4)). THE NEEDLE HAS BEEN SURGICALLY REMOVED. WE MADE ANALYSIS OF THE SAMPLE OF THE SAME LOT WITH RESULT: COMPLIANCE. DURING THE LOT RELEASE WERE CONTROLLED, (B)(4) PEN NEEDLES IN ORDER TO CHECK THE CONFORMITY OF THE PRODUCT ACCORDING TO THE INJECTION, AND THE RESULT WAS: COMPLIANCE. THE OTHER CONTROLS PERFORMED WERE: VISUAL CONTROL WITH MAGNIFIER AT 40 INCREASES (ISO 11608-2 THAT REFERS TO ISO 7864 RECOMMEND A CONTROL AT 2,5 INCREASES, IT MEANS THAT OUR CONTROL IS STRICHTER). INJECTION CONTROL ACCORDING TO (B)(4). CONTROL AT 100% OF THE NEEDLE OBTURATION.

Description of Event or Problem · 1

THE PEN NEEDLE HAS BROKEN INSIDE THE ABDOMEN OF THE PT ((B)(4)). THE NEEDLE HAS BEEN SURGICALLY REMOVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PIC INSUPEN PEN NEEDLE FMI ARTSANA S.P.A. 104100372

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization